Invesco SandP 500 Equal Weight Consumer Discretionary ETF (RSPD)
Live price chart, market sentiment, and community perspectives for Invesco SandP 500 Equal Weight Consumer Discretionary ETF (AMEX: RSPD).
Live price chart, market sentiment, and community perspectives for Invesco SandP 500 Equal Weight Consumer Discretionary ETF (AMEX: RSPD).
On our desk, we are monitoring the Discretionary-to-Staples ratio closely as it just broke to its lowest level since June, echoing historical warning signs seen prior to major market pullbacks. Even though the SandP 500 hits all-time highs, this relative weakness in RSPD against staples suggests underlying cyclical caution that macro allocators cannot ignore.
Looking at RSPD from a quantitative portfolio construction lens, the equal-weight methodology sounds appealing on paper for diversification, but it continuously trails market-cap alternatives like IVV. The forward EPS, revenue, and EBITDA growth rates just do not measure up, and its GARP profile remains unconvincing despite a higher earnings yield.
From a risk management standpoint, RSPD has disappointed by failing to generate superior risk-adjusted returns relative to IVV or XLY. Its standard deviation is surprisingly high for an equal-weight basket in this sector, complicating our risk modeling and limiting its upside potential as a standalone allocation.
Sentiment on the retail sector is bifurcated. While the Q2 U.S. Retail Preview highlights a massive 231.1% surge in Broadline Retail earnings growth driven by consumer resilience, this strength is heavily concentrated, meaning RSPD's equal-weight exposure might not capture these specific high-growth leaders as efficiently as cap-weighted funds.
Our short interest tracking shows RSPD short interest dropped significantly by 46.5% down to 26,803 shares (representing just 0.49% of the float) with a days-to-cover ratio of 0.3. This tiny short footprint indicates that bearish conviction is not currently being expressed via direct shorting of the ETF wrapper itself.
Explore plasma cleansing, somatic organ swaps, and BCI.